42 related articles for article (PubMed ID: 8667063)
1. 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice.
Liu Z; Stevenson GD; Barrett HH; Kastis GA; Bettan M; Furenlid LR; Wilson DW; Woolfenden JM; Pak KY
Nucl Med Commun; 2004 Jul; 25(7):711-20. PubMed ID: 15208499
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo-derived
Lopez BP; Kappadath SC
Med Phys; 2023 May; 50(5):2985-2997. PubMed ID: 36583691
[TBL] [Abstract][Full Text] [Related]
3. Radionuclide-Based Imaging of Breast Cancer: State of the Art.
Li H; Liu Z; Yuan L; Fan K; Zhang Y; Cai W; Lan X
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771622
[TBL] [Abstract][Full Text] [Related]
4.
Tesan FC; Nicoud MB; Nuñez M; Medina VA; Chiappetta DA; Salgueiro MJ
Contrast Media Mol Imaging; 2019; 2019():4087895. PubMed ID: 31178670
[TBL] [Abstract][Full Text] [Related]
5. (99m)Tc(N)-DBODC(5), a potential radiolabeled probe for SPECT of multidrug resistance: in vitro study.
Bolzati C; Carta D; Gandin V; Marzano C; Morellato N; Salvarese N; Cantore M; Colabufo NA
J Biol Inorg Chem; 2013 Jun; 18(5):523-38. PubMed ID: 23543234
[TBL] [Abstract][Full Text] [Related]
6. Transport processes of radiopharmaceuticals and -modulators.
Efferth T; Langguth P
Radiat Oncol; 2011 Jun; 6():59. PubMed ID: 21645349
[TBL] [Abstract][Full Text] [Related]
7. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.
Batrakova EV; Li S; Brynskikh AM; Sharma AK; Li Y; Boska M; Gong N; Mosley RL; Alakhov VY; Gendelman HE; Kabanov AV
J Control Release; 2010 May; 143(3):290-301. PubMed ID: 20074598
[TBL] [Abstract][Full Text] [Related]
8. Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model.
Vanpouille C; Le Jeune N; Kryza D; Clotagatide A; Janier M; Dubois F; Perek N
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1256-64. PubMed ID: 19300998
[TBL] [Abstract][Full Text] [Related]
9. Visualisation of a paraganglioma by technetium-99m-sestamibi scintigraphy.
Piga M; Farina GP; Loi GL; Serra A; Calia MA; Lai L; Zucca G; Mariotti S
J Endocrinol Invest; 1999 Apr; 22(4):296-300. PubMed ID: 10342364
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-sesta-(2-methoxy-isobutyl-isonitrile) uptake by pancreatic islets, parotid cells, and mammary carcinoma cells.
Blocklet D; Jijakli H; Sener A; Schoutens A; Malaisse WJ
Endocrine; 1998 Aug; 9(1):113-7. PubMed ID: 9798738
[TBL] [Abstract][Full Text] [Related]
11. Use of 99mTc-MIBI scintigraphy in the evaluation of the response of osteosarcoma to chemotherapy.
Söderlund V; Larsson SA; Bauer HC; Brosjö O; Larsson O; Jacobsson H
Eur J Nucl Med; 1997 May; 24(5):511-5. PubMed ID: 9142731
[TBL] [Abstract][Full Text] [Related]
12. Comparison of cationic myocardial perfusion agents: characteristics of accumulation in cultured smooth muscle cells.
Nakamura K; Sammiya T; Hashimoto J; Ishibashi R; Matsumoto K; Kubo A
Ann Nucl Med; 1996 Nov; 10(4):375-81. PubMed ID: 9006721
[TBL] [Abstract][Full Text] [Related]
13. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression.
Moretti JL; Azaloux H; Boisseron D; Kouyoumdjian JC; Vilcoq J
Eur J Nucl Med; 1996 Aug; 23(8):980-6. PubMed ID: 8753690
[TBL] [Abstract][Full Text] [Related]
14. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression.
Cordobes MD; Starzec A; Delmon-Moingeon L; Blanchot C; Kouyoumdjian JC; Prévost G; Caglar M; Moretti JL
J Nucl Med; 1996 Feb; 37(2):286-9. PubMed ID: 8667063
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-sestamibi imaging in the assessment of toremifene as a modulator of multidrug resistance in patients with breast cancer.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Sinnett D; Glass DM; Peters AM
J Nucl Med; 2002 Apr; 43(4):519-25. PubMed ID: 11937596
[TBL] [Abstract][Full Text] [Related]
16. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.
Moretti JL; Duran Cordobes M; Starzec A; de Beco V; Vergote J; Benazzouz F; Boissier B; Cohen H; Safi N; Piperno-Neumann S; Kouyoumdjian JC
J Nucl Med; 1998 Jul; 39(7):1214-8. PubMed ID: 9669397
[TBL] [Abstract][Full Text] [Related]
17. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.
Del Vecchio S; Ciarmiello A; Pace L; Potena MI; Carriero MV; Mainolfi C; Thomas R; D'Aiuto G; Tsuruo T; Salvatore M
J Nucl Med; 1997 Sep; 38(9):1348-51. PubMed ID: 9293785
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance: lessons from clinical oncology.
Bates SF; Chen C; Robey R; Kang M; Figg WD; Fojo T
Novartis Found Symp; 2002; 243():83-96; discussion 96-102, 180-5. PubMed ID: 11990784
[TBL] [Abstract][Full Text] [Related]
19. Clinical imaging of multidrug resistance in cancer.
Del Vecchio S; Ciarmiello A; Salvatore M
Q J Nucl Med; 1999 Jun; 43(2):125-31. PubMed ID: 10429507
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
